Want to see IN:LOTUSEYE full AI Analyst Report?
LOTUSEYE Stock Chart & Stats
₹118.10
-₹0.92(-1.30%)
At close: 4:00 PM EST
₹118.10
-₹0.92(-1.30%)
Day’s Range― - ―
52-Week Range₹97.60 - ₹153.00
Previous CloseN/A
Volume15.88K
Average Volume (3M)1.81K
Market Cap
₹2.36B
Enterprise Value₹2.23K
Total Cash (Recent Filing)₹38.27M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)1418.8
Beta0.83
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.59%
Share Statistics
EPS (TTM)0.08
Shares Outstanding20,796,330
10 Day Avg. Volume2,611
30 Day Avg. Volume1,814
Financial Highlights & Ratios
PEG Ratio-27.83
Price to Book (P/B)3.28
Price to Sales (P/S)3.68
P/FCF Ratio-18.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSteady revenue growth indicates continuing demand for the company’s ophthalmology consultations, diagnostics, and procedures. While growth is moderate, repeated top-line expansion supports the durability of its healthcare service model and provides a base for recovery if operating efficiency improves.
Equity-Supported Balance SheetEquity substantially exceeds debt, providing a meaningful capital base relative to borrowings and some protection against financial stress. This support can help the company maintain hospital operations and pursue necessary investment while management works to restore profitability.
Positive Operating Cash FlowPositive operating cash flow shows that the core business still generated cash from operations despite very low reported earnings. Although the amount has declined from earlier periods, continued operational cash generation offers some internal funding capacity and supports ongoing clinical activity.
Bears Say
Severe Margin DeteriorationProfitability has weakened to exceptionally thin net margins, while operating losses indicate that routine hospital activity is not currently covering operating costs. Unless margins recover, revenue growth may create little earnings benefit and leave less cash available for reinvestment or debt service.
Rapidly Rising LeverageThe sharp increase in leverage raises financial risk at the same time that earnings have deteriorated. More debt relative to equity can increase repayment and financing pressure, reduce flexibility for hospital investment, and make the business more vulnerable if weak profitability persists.
Deeply Negative Free Cash FlowRepeatedly negative free cash flow means operating cash has not been sufficient to fund investment and other cash requirements. The resulting funding need can constrain expansion, increase reliance on external capital, and weaken financial resilience while net income remains minimal.
Lotus Eye Hospital And Institute Ltd News
LOTUSEYE FAQ
What was Lotus Eye Hospital And Institute Ltd’s price range in the past 12 months?
Lotus Eye Hospital And Institute Ltd lowest stock price was ₹97.60 and its highest was ₹153.00 in the past 12 months.
What is Lotus Eye Hospital And Institute Ltd’s market cap?
Lotus Eye Hospital And Institute Ltd’s market cap is ₹2.36B.
When is Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date?
Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date is Nov 17, 2026 which is in 63 days.
How were Lotus Eye Hospital And Institute Ltd’s earnings last quarter?
Lotus Eye Hospital And Institute Ltd released its earnings results on Aug 10, 2026. The company reported ₹0.295 earnings per share for the quarter.
Is Lotus Eye Hospital And Institute Ltd overvalued?
According to Wall Street analysts Lotus Eye Hospital And Institute Ltd’s price is currently Overvalued.
Does Lotus Eye Hospital And Institute Ltd pay dividends?
Lotus Eye Hospital And Institute Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.59%. See more information on Lotus Eye Hospital And Institute Ltd dividends here
What is Lotus Eye Hospital And Institute Ltd’s EPS estimate?
Lotus Eye Hospital And Institute Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Eye Hospital And Institute Ltd have?
Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding.
What happened to Lotus Eye Hospital And Institute Ltd’s price movement after its last earnings report?
Lotus Eye Hospital And Institute Ltd reported an EPS of ₹0.295 in its last earnings report. Following the earnings report the stock price went down -0.171%.
Which hedge fund is a major shareholder of Lotus Eye Hospital And Institute Ltd?
Currently, no hedge funds are holding shares in IN:LOTUSEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lotus Eye Hospital And Institute Ltd
Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and cornea infections, as well as various eye related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Aster DM Healthcare Ltd.
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―